Controlled aggregation of primary human pancreatic islet cells leads to glucose‐responsive pseudoislets comparable to native islets. Issue 8 (17th March 2015)
- Record Type:
- Journal Article
- Title:
- Controlled aggregation of primary human pancreatic islet cells leads to glucose‐responsive pseudoislets comparable to native islets. Issue 8 (17th March 2015)
- Main Title:
- Controlled aggregation of primary human pancreatic islet cells leads to glucose‐responsive pseudoislets comparable to native islets
- Authors:
- Hilderink, Janneke
Spijker, Siebe
Carlotti, Françoise
Lange, Lydia
Engelse, Marten
van Blitterswijk, Clemens
de Koning, Eelco
Karperien, Marcel
van Apeldoorn, Aart - Abstract:
- <abstract abstract-type="main" id="jcmm12555-abs-0001"> <title>Abstract</title> <p>Clinical islet transplantation is a promising treatment for patients with type 1 diabetes. However, pancreatic islets vary in size and shape affecting their survival and function after transplantation because of mass transport limitations. To reduce diffusion restrictions and improve islet cell survival, the generation of islets with optimal dimensions by dispersion followed by reassembly of islet cells, can help limit the length of diffusion pathways. This study describes a microwell platform that supports the controlled and reproducible production of three‐dimensional pancreatic cell clusters of human donor islets. We observed that primary human islet cell aggregates with a diameter of 100–150 μm consisting of about 1000 cells best resembled intact pancreatic islets as they showed low apoptotic cell death (&lt;2%), comparable glucose‐responsiveness and increasing <italic>PDX1</italic>, <italic> MAFA</italic> and <italic>INSULIN</italic> gene expression with increasing aggregate size. The re‐associated human islet cells showed an a‐typical core shell configuration with beta cells predominantly on the outside unlike human islets, which became more randomized after implantation similar to native human islets. After transplantation of these islet cell aggregates under the kidney capsule of immunodeficient mice, human C‐peptide was detected in the serum indicating that beta cells retained their<abstract abstract-type="main" id="jcmm12555-abs-0001"> <title>Abstract</title> <p>Clinical islet transplantation is a promising treatment for patients with type 1 diabetes. However, pancreatic islets vary in size and shape affecting their survival and function after transplantation because of mass transport limitations. To reduce diffusion restrictions and improve islet cell survival, the generation of islets with optimal dimensions by dispersion followed by reassembly of islet cells, can help limit the length of diffusion pathways. This study describes a microwell platform that supports the controlled and reproducible production of three‐dimensional pancreatic cell clusters of human donor islets. We observed that primary human islet cell aggregates with a diameter of 100–150 μm consisting of about 1000 cells best resembled intact pancreatic islets as they showed low apoptotic cell death (&lt;2%), comparable glucose‐responsiveness and increasing <italic>PDX1</italic>, <italic> MAFA</italic> and <italic>INSULIN</italic> gene expression with increasing aggregate size. The re‐associated human islet cells showed an a‐typical core shell configuration with beta cells predominantly on the outside unlike human islets, which became more randomized after implantation similar to native human islets. After transplantation of these islet cell aggregates under the kidney capsule of immunodeficient mice, human C‐peptide was detected in the serum indicating that beta cells retained their endocrine function similar to human islets. The agarose microwell platform was shown to be an easy and very reproducible method to aggregate pancreatic islet cells with high accuracy providing a reliable tool to study cell–cell interactions between insuloma and/or primary islet cells.</p> </abstract> … (more)
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 19:Issue 8(2015)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 19:Issue 8(2015)
- Issue Display:
- Volume 19, Issue 8 (2015)
- Year:
- 2015
- Volume:
- 19
- Issue:
- 8
- Issue Sort Value:
- 2015-0019-0008-0000
- Page Start:
- 1836
- Page End:
- 1846
- Publication Date:
- 2015-03-17
- Subjects:
- Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.12555 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3084.xml